Tempest Therapeutics, Inc.
TPST
$3.03
-$0.03-0.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.05M | -43.10M | -44.80M | -41.84M | -35.52M |
| Total Depreciation and Amortization | 250.00K | 281.00K | 369.00K | 389.00K | 425.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.08M | 6.38M | 6.70M | 6.81M | 6.75M |
| Change in Net Operating Assets | -2.67M | -355.00K | 3.85M | 1.61M | -705.00K |
| Cash from Operations | -33.40M | -36.80M | -33.88M | -33.03M | -29.05M |
| Capital Expenditure | -3.00K | -18.00K | -267.00K | -435.00K | -439.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -18.00K | -267.00K | -435.00K | -439.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.63M | -10.82M | -6.60M | -4.40M | -2.20M |
| Issuance of Common Stock | 25.21M | 28.94M | 29.93M | 28.90M | 43.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.86M | 1.86M | -- | -- | -- |
| Cash from Financing | 18.44M | 19.97M | 23.33M | 24.50M | 40.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.95M | -16.84M | -10.82M | -8.96M | 11.41M |